2.92HKD
2.20 BHKD
6.96 BHKD
405.25 M
About YICHANG HEC CHANGJIANG PHARMACTL CO
Sector
CEO
Jun Cai Jiang
Headquarters
Yichang
Website
Employees (FY)
4.62 K
Founded
2001
ISIN
CNE1000023R6
FIGI
BBG00BNKGQL7
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and others. Its products include Benzbromarone, Telmisartan, Amlodipine Besylate, and Cetirizine Hydrochloride. The company was founded on August 8, 2001 and is headquartered in Yichang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1558 is 12.36 HKD — it has increased by 1.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange YICHANG HEC CHANGJIANG PHARMACTL CO stocks are traded under the ticker 1558.
YICHANG HEC CHANGJIANG PHARMACTL CO is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
1558 stock is 1.98% volatile and has beta coefficient of 0.99. Check out the list of the most volatile stocks — is YICHANG HEC CHANGJIANG PHARMACTL CO there?
One year price forecast for YICHANG HEC CHANGJIANG PHARMACTL CO has a max estimate of 14.00 HKD and a min estimate of 14.00 HKD.
Yes, you can track YICHANG HEC CHANGJIANG PHARMACTL CO financials in yearly and quarterly reports right on TradingView.
1558 stock has fallen by 2.37% compared to the previous week, the month change is a 15.30% rise, over the last year YICHANG HEC CHANGJIANG PHARMACTL CO has showed a 67.48% increase.
1558 net income for the last quarter is 1.04 B HKD, while the quarter before that showed 1.16 B HKD of net income which accounts for −10.63% change. Track more YICHANG HEC CHANGJIANG PHARMACTL CO financial stats to get the full picture.
Today YICHANG HEC CHANGJIANG PHARMACTL CO has the market capitalization of 10.75 B, it has increased by 9.74% over the last week.
YICHANG HEC CHANGJIANG PHARMACTL CO dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1558 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YICHANG HEC CHANGJIANG PHARMACTL CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 4.62 K employees. See our rating of the largest employees — is YICHANG HEC CHANGJIANG PHARMACTL CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YICHANG HEC CHANGJIANG PHARMACTL CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YICHANG HEC CHANGJIANG PHARMACTL CO stock shows the strong buy signal. See more of YICHANG HEC CHANGJIANG PHARMACTL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on YICHANG HEC CHANGJIANG PHARMACTL CO future price: according to them, 1558 price has a max estimate of 14.00 HKD and a min estimate of 14.00 HKD. Read a more detailed YICHANG HEC CHANGJIANG PHARMACTL CO forecast: see what analysts think of YICHANG HEC CHANGJIANG PHARMACTL CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YICHANG HEC CHANGJIANG PHARMACTL CO EBITDA is 3.59 B HKD, and current EBITDA margin is 51.57%. See more stats in YICHANG HEC CHANGJIANG PHARMACTL CO financial statements.